**Core Concept**
Proton pump inhibitors (PPIs) are a class of medications that reduce gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cells. This mechanism is crucial in preventing NSAID-induced peptic ulcer disease.

**Why the Correct Answer is Right**
The use of NSAIDs leads to the inhibition of prostaglandin synthesis, resulting in a decrease in the protective effects of prostaglandins on the gastric mucosa. PPIs effectively reduce gastric acid production, thereby protecting the gastric mucosa from the erosive effects of NSAIDs. The potent acid suppression achieved with PPIs is more effective in preventing NSAID-induced peptic ulcer disease compared to other classes of medications. This is particularly relevant in patients who require long-term NSAID therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** H2 receptor blockers, such as ranitidine, also reduce gastric acid secretion by blocking histamine receptors. However, they are less potent than PPIs in preventing NSAID-induced peptic ulcer disease.

**Option C:** Macrolide antibiotics, such as erythromycin, may have some gastroprotective effects due to their ability to increase prostaglandin production. However, they are not the primary choice for preventing NSAID-induced peptic ulcer disease.

**Option D:** Sucralfate forms an ulcer-adherent complex that protects the ulcer site from acid and pepsin. While it can help in healing existing ulcers, it is not as effective as PPIs in preventing NSAID-induced peptic ulcer disease.

**Clinical Pearl / High-Yield Fact**
When managing patients on long-term NSAID therapy, it is essential to consider the use of a PPI to prevent NSAID-induced peptic ulcer disease. This is particularly relevant in patients with a history of peptic ulcer disease, Helicobacter pylori infection, or those taking other medications that increase the risk of peptic ulcers.

**Correct Answer:**
✓ Correct Answer: B. Proton pump inhibitors